Uburyo bwo kuvura indwara ya CAR-T ku ndwara ya Myeloma nyinshi (MM)

Myeloma nyinshi (MM) ni ubwoko bwa kanseri yibasira uturemangingo tw’amaraso mu musemburo w’amagufwa. Izwiho imiterere yayo igoye kandi ihindagurika, akenshi igatera gusubira inyuma no kudakira imiti gakondo. Nubwo imiti ya chimiotherapie, gutera uturemangingo tw’ingirabuzima fatizo, n’imiti mishya byagize ingaruka nziza, abarwayi benshi amaherezo bahura n’ubudakira bwo kuvurwa. Ubuvuzi bwa CAR-T (Chimeric Antigen Receptor T-cell) ni uburyo bw’ingenzi bwagaragaje ko bufite intsinzi itangaje mu kuvura myeloma nyinshi yasubiwemo kandi idashobora kuvura, butanga igisubizo cyiza ku barwayi bafite amahitamo make.

Ubuvuzi bwa CAR-T bukubiyemo guhindura uturemangingo twa T tw’umurwayi kugira ngo tumenye neza kandi twibasire uturemangingo twa kanseri. Kuri myeloma nyinshi, uturemangingo twa CAR-T twakozwe kugira ngo twibasire BCMA (antigen yo gukura kwa selile B), poroteyine iboneka ku buso bw’uturemangingo twa myeloma. Nyuma yo guhindurwa mu buryo bwa genetiki, utwo turemangingo twa T twongerwa mu mubiri w’umurwayi, aho dushaka no gusenya uturemangingo twa kanseri, bishobora gutuma akira neza kandi akarokoka igihe kirekire.

• Ingufu nyinshi mu gusubira inyuma/gusubira inyuma MM: Ubuvuzi bwa CAR-T bwagaragaje ko bufite icyo bugeraho ku barwayi ba myeloma nyinshi basubiye inyuma cyangwa barwaye indwara ya myeloma nyinshi, akenshi bakaba barageze ku rwego rwo kuruhuka burundu cyangwa indwara ntoya isigara (MRD).
• Uburyo bwo Kwita ku ntego: Mu kwibanda kuri BCMA, ubuvuzi bwa CAR-T bwibasira neza uturemangingo twa myeloma, burinda ingirabuzima fatizo nziza kandi bukagabanya ingaruka mbi ugereranije n’ubuvuzi busanzwe.
• Byakozwe ku giti cye kandi bishya: Ubu buvuzi bukoresha uturemangingo twa T tw'umurwayi, butuma habaho gahunda yo kuvura yihariye. Ibi kandi bifasha kugabanya ibyago byo kwangwa.
• Imbabazi z'igihe kirekire: Abarwayi benshi bavuwe hakoreshejwe CAR-T therapy babona ibisubizo birambye, bamwe bagakomeza koroherwa imyaka myinshi, ndetse na nyuma y’uko ubundi buryo bwo kuvura bwananiranye.

• Gukusanya uturemangingo twa TIntambwe ya mbere ikubiyemo gukusanya uturemangingo twa T mu maraso y'umurwayi hakoreshejwe leukapheresis, igikorwa nk'icyo gutanga amaraso.
• Gutunganya uturemangingo twa T: Izi selile T zoherezwa muri laboratwari, aho zihindurwamo imiterere y’uturemangingo kugira ngo zigaragaze CAR yihariye kuri BCMA, bikongera ubushobozi bwazo bwo kumenya no kwica selile za myeloma.
• Guteranya uturemangingo twa CAR-T: Nyuma yo kwaguka muri laboratwari, uturemangingo twa T twakozwe mu buryo bwa tekiniki twongera gushyirwa mu maraso y'umurwayi binyuze mu muyoboro wa IV.
• Gukurikirana no Gusubiza mu buzima busanzwe: Nyuma yo guterwa imiti, abarwayi bakurikiranwa kugira ngo barebe ingaruka mbi zishobora kubaho nka cytokine release syndrome (CRS) cyangwa uburozi bw'ubwonko. Izi ngaruka mbi akenshi zirashobora gukemurwa n'ubuvuzi no gukurikiranwa.

• Ikoranabuhanga rigezweho rya CAR-TBIOOCUS ikoresha iterambere rigezweho mu ikoranabuhanga rya CAR-T kugira ngo itange ubuvuzi bwiza kandi butange umusaruro mwiza ku barwayi ba MM.
• Ubuhanga mu by'ubuvuzi bwo ku rwego rw'isi: Itsinda ryacu ry’inzobere mu by’amaraso n’ubuvuzi bw’ubudahangarwa bw’umubiri ritanga ubuvuzi bwihariye, rituma buri murwayi abona ubuvuzi bwiza bushoboka bitewe n’uburwayi bwe bwihariye.
• Amateka yemejwe: Twavuje abarwayi benshi ba MM dukoresheje CAR-T therapy, kandi benshi bageze ku bunararibonye butangaje kandi burambye.
• Ubufasha bwuzuye ku barwayi mpuzamahangaBIOOCUS itanga ubufasha bwuzuye ku barwayi mpuzamahanga, ikakuyobora muri buri ntambwe yo kuvurwa, kuva ku nama y'ibanze kugeza ku buvuzi nyuma yo kuvurwa.

• Ibimenyetso by'ubuvuzi n'igipimo cy'intsinzi

  Ubuvuzi bwa CAR-T ku ndwara ya myeloma nyinshi bwagaragaje umusaruro utangaje mu igeragezwa ry’ubuvuzi no mu buzima busanzwe. By’umwihariko, bwagaragaje ko bufite akamaro ku barwayi bongeye kurwara nyuma yo kuvurwa inshuro nyinshi, bamwe bakaba barakize burundu cyangwa badafite MRD.

  • Inkuru y'umurwayi: Kugera ku ruhu rw'igihe kirekire hamwe na CAR-T kuri Myeloma nyinshi
  • Inyigo y'Urugero: Igisubizo cyuzuye nyuma yo kuvurwa na CAR-T muri Myeloma nyinshi yasubiwemo
  • Akamaro k'ubuvuzi bwa CAR-T mu kuvura indwara ya Myeloma nyinshi yasubiwemo/ifite uburwayi bwo kubura umwuka

  Ubu bushakashatsi bwerekana uburyo ubuvuzi bwa CAR-T burimo guhindura imiterere y’ubuvuzi bwa myeloma nyinshi, buha abarwayi icyizere cyo kubaho igihe kirekire no kunoza ubuzima bwabo.

Ibimenyetso bya CD19+20CAR-T:Abarwayi bafite lymphoma ya B-cell non Hodgkin

Ibimenyetso bya CD19+22CAR-T:Kuvura abarwayi ba kanseri y'amaraso ya B-lymphocytic basubiye inyuma kandi badafite CD19

Ibimenyetso bya BCMACAR-T:Kuvura myeloma nyinshi yasubiwemo kandi idashobora kuvura